These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6477534)

  • 1. Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts.
    Wendel U; Langenbeck U
    Biochem Med; 1984 Jun; 31(3):294-302. PubMed ID: 6477534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
    Schadewaldt P; Wendel U
    Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts.
    Schadewaldt P; Radeck W; Hammen HW; Wendel U
    Pediatr Res; 1988 Jan; 23(1):40-4. PubMed ID: 3340442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maple syrup urine disease: alpha-ketoisocaproate decarboxylation activity in different types of cultured amniotic fluid cells.
    Wendel U; Gamm G; Claussen U
    Prenat Diagn; 1981 Oct; 1(4):235-40. PubMed ID: 7346826
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the catabolism of branched-chain L-amino acids in cultured human skin fibroblasts.
    Schadewaldt P; Wendel U
    Pediatr Res; 1987 Nov; 22(5):591-4. PubMed ID: 3684388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
    Wendel U; Wentrup H; Rüdiger HW
    Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
    Jouvet P; Kozma M; Mehmet H
    Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
    Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
    Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for assay of branched-chain keto acid decarboxylation in cultured cells and its application to prenatal diagnosis of maple syrup urine disease.
    Fensom AH; Benson PF; Baker JE
    Clin Chim Acta; 1978 Jul; 87(1):169-74. PubMed ID: 668138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.
    Dancis J; Hutzler J; Cox RP
    Am J Hum Genet; 1977 May; 29(3):272-9. PubMed ID: 868873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.
    Wendel U; Langenbeck U; Lombeck I; Bremer HJ
    Eur J Pediatr; 1982 Jul; 138(4):293-6. PubMed ID: 7128634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of branched-chain amino acids in fibroblasts from patients with maple syrup urine disease and other abnormalities of branched-chain ketoacid dehydrogenase activity.
    Yoshida I; Sweetman L; Nyhan WL
    Pediatr Res; 1986 Feb; 20(2):169-74. PubMed ID: 3080729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.
    Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U
    J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease.
    Tribble D; Shapira R
    Biochem Biophys Res Commun; 1983 Jul; 114(2):440-6. PubMed ID: 6411085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.
    Singh S; Willers I; Goedde HW
    Clin Genet; 1977 Apr; 11(4):277-84. PubMed ID: 192504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of maple syrup urine disease in cell culture: use of substrates.
    Schadewaldt P; Beck K; Wendel U
    Clin Chim Acta; 1989 Sep; 184(1):47-56. PubMed ID: 2598467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.